文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

葡萄糖酸氯己定口腔护理对住院死亡率的影响:一项全院观察性队列研究

Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study.
PubMed 文献 · Intensive Care Med · 2018-05-09
一句话结论全院回顾性队列显示,低剂量氯己定口腔护理与死亡风险升高相关(OR 2.61),但在ICU机械通气与非机械通气患者中未见有害效应。

该单中心、回顾性、全院观察性队列纳入2012—2014年成人住院患者82,274例,其中11,133例(14%)接受氯己定口腔护理。以累积剂量300 mg为二分暴露代理,低剂量暴露(≤300 mg)与死亡风险升高相关(OR 2.61;95%CI 2.32—2.92),且死亡风险越低的人群关联越强:轻微/中等风险OR 5.50(95%CI 4.51—6.71),重大风险OR 2.33(95%CI 1.96—2.78),极高风险OR 1.13(95%CI 0.90—1.41,未达显著)。高剂量暴露(>300 mg)结果类似。在ICU机械通气与非机械通气患者中未见有害效应;未接受机械通气且未入住ICU的患者死亡风险升高。调整后需暴露人数(NNH)为47.1(95%CI 45.2—49.1)。作者认为,在特定人群获益未获证实前,这些数据不支持不加区分地广泛使用氯己定口腔护理。

要点

  • 在全院成人住院患者中,低剂量氯己定口腔护理(≤300 mg)与死亡风险升高相关:OR 2.61(95%CI 2.32—2.92)。
  • 死亡风险越低的人群关联越强:轻微/中等风险OR 5.50(95%CI 4.51—6.71),重大风险OR 2.33(95%CI 1.96—2.78),极高风险OR 1.13(95%CI 0.90—1.41,未达显著)。
  • 高剂量暴露(>300 mg)结果与低剂量暴露类似。
  • 在ICU机械通气与非机械通气患者中未观察到有害效应;未接受机械通气且未入住ICU的患者死亡风险升高。
  • 调整后NNH为47.1(95%CI 45.2—49.1)。

适用人群与场景

  • 2012—2014年单中心全院住院成人患者,共82,274例,其中11,133例(14%)接受氯己定口腔护理。
  • 研究包含ICU与非ICU、机械通气与非机械通气患者。

诊断标准与关键阈值

  • 以累积剂量300 mg作为氯己定暴露的二分代理阈值:低剂量暴露≤300 mg,高剂量暴露>300 mg。
  • 死亡风险评估分为四类:轻微、中等、重大、极高。

研究设计与关键结果

  • 研究类型:单中心、回顾性、全院观察性队列研究,纳入成人住院患者82,274例,其中11,133例(14%)接受氯己定口腔护理。
  • 低剂量暴露(≤300 mg)与死亡风险升高相关:OR 2.61(95%CI 2.32—2.92);高剂量暴露(>300 mg)结果类似。
  • 按死亡风险分层:轻微/中等风险OR 5.50(95%CI 4.51—6.71),重大风险OR 2.33(95%CI 1.96—2.78),极高风险OR 1.13(95%CI 0.90—1.41,未达显著)。
  • 在ICU机械通气与非机械通气患者中未观察到有害效应;未接受机械通气且未入住ICU的患者死亡风险升高。
  • 调整后NNH为47.1(95%CI 45.2—49.1)。

证据类型、等级与局限

  • 证据类型:单中心、回顾性、全院观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在特定人群获益未获证实前,这些数据不支持不加区分地广泛使用氯己定口腔护理。
  • 在ICU机械通气与非机械通气患者中未观察到有害效应;未接受机械通气且未入住ICU的患者死亡风险升高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Chlorhexidine oral care is widely used in critically and non-critically ill hospitalized patients to maintain oral health. We investigated the effect of chlorhexidine oral care on mortality in a general hospitalized population.

METHODS: In this single-center, retrospective, hospital-wide, observational cohort study we included adult hospitalized patients (2012-2014). Mortality associated with chlorhexidine oral care was assessed by logistic regression analysis. A threshold cumulative dose of 300 mg served as a dichotomic proxy for chlorhexidine exposure. We adjusted for demographics, diagnostic category, and risk of mortality expressed in four categories (minor, moderate, major, and extreme).

RESULTS: The study cohort included 82,274 patients of which 11,133 (14%) received chlorhexidine oral care. Low-level exposure to chlorhexidine oral care (≤ 300 mg) was associated with increased risk of death [odds ratio (OR) 2.61; 95% confidence interval (CI) 2.32-2.92]. This association was stronger among patients with a lower risk of death: OR 5.50 (95% CI 4.51-6.71) with minor/moderate risk, OR 2.33 (95% CI 1.96-2.78) with a major risk, and a not significant OR 1.13 (95% CI 0.90-1.41) with an extreme risk of mortality. Similar observations were made for high-level exposure (> 300 mg). No harmful effect was observed in ventilated and non-ventilated ICU patients. Increased risk of death was observed in patients who did not receive mechanical ventilation and were not admitted to ICUs. The adjusted number of patients needed to be exposed to result in one additional fatality case was 47.1 (95% CI 45.2-49.1).

CONCLUSIONS: These data argue against the indiscriminate widespread use of chlorhexidine oral care in hospitalized patients, in the absence of proven benefit in specific populations.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Deschepper M, Waegeman W, Eeckloo K, et al. Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study. Intensive Care Med. 2018. PMID: 29744564. doi:10.1007/s00134-018-5171-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。